Horizon Therapeutics U.S. Holding LLC et al v. Teva Pharmaceuticals, Inc.
| Horizon Therapeutics U.S. Holding LLC and Horizon Therapeutics USA, Inc. |
| Teva Pharmaceuticals, Inc. |
| 1:2024cv00432 |
| April 5, 2024 |
| US District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 5, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 Pro Hac Vice Fee - Credit Card Payment received for Christine Ranney, Josh Krevitt, Wayne Barsky, and Andrew Blythe. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney )( Payment of $ 200, receipt number ADEDC-4378803).(Sharp, Melanie) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorneys Christine Ranney, Esq., Josh Krevitt, Esq., Wayne Barsky, Esq., and Andrew Blythe, Esq. - filed by Horizon Therapeutics U.S. Holding LLC, Horizon Therapeutics USA, Inc.(oam) |
| Filing 7 Summons Issued as to Teva Pharmaceuticals, Inc. on 4/5/2024. (oam) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for Horizon Therapeutics USA, Inc. filed by Horizon Therapeutics USA, Inc.. (oam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Horizon Therapeutics USA, Inc. for Horizon Therapeutics U.S. Holding LLC filed by Horizon Therapeutics U.S. Holding LLC. (oam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,642,012; 9,254,278; 9,326,966; 9,561,197 ; 9,962,359. (oam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/22/2024. Date of Expiration of Patent: 09/22/2030.Thirty Month Stay Deadline: 8/22/2026. (oam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 1 COMPLAINT filed for PATENT INFRINGEMENT against Teva Pharmaceuticals, Inc. ( Filing fee $ 405, receipt number ADEDC-4378505.) - filed by Horizon Therapeutics USA, Inc., Horizon Therapeutics U.S. Holding LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Civil Cover Sheet)(oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
